TNF Pharmaceuticals announced that it has changed its corporate name to Q/C Technologies and will begin trading under the new ticker symbol (QCLS) on Nasdaq, effective as of the market open on Thursday, September 25. Until then, the company’s common stock will continue to trade under its current ticker symbol (TNFA). The company also noted that it continues to evaluate strategic options for its legacy therapeutic programs, isomyosamine and Supera-CBD.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TNFA:
- TNF Pharmaceuticals regains compliance with Nasdaq
- TNF Pharmaceuticals Secures $7M in Private Placement
- TNF Pharmaceuticals Enters Licensing Agreement with LightSolver
- PharmaCyte Biotech increases stake in TNF Pharmaceuticals by $3M
- TNF Pharmaceuticals gets rights to LightSolver tech for crypto applications